Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
68,523
Sort by:
North America Smart Biopsy Market (2019-2025)
US$ 1,500.00
The North America Smart Biopsy Market would witness market growth of 4.53% CAGR during the forecast period (2019-2025). Smart biopsy assists in the diagnosis of cancer and helps to distinguish between...
November 2019
83 pages
North America Teleradiology Market (2019-2025)
US$ 1,500.00
The North America Teleradiology Market would witness market growth of 16.46% CAGR during the forecast period (2019-2025). Teleradiology improves customer service by assisting radiologists in providing...
November 2019
61 pages
Healthcare Chatbots Market by Application (Symptoms Check, Medical and Drug Information Assistance, Appointment Scheduling and Monitoring, and Other applications), Deployment (Cloud-based and On-premise), and End User (Healthcare Providers, Healthcare Payers, Patients and Other End Users): Global Opportunity Analysis and Industry Forecast, 2018–2026
US$ 5,370.00
The global healthcare chatbots market accounted for $116.9 million in 2018 and is expected to reach $345.3 million by 2026, registering a CAGR of 14.5% from 2019 to 2026. A chatbot is a program that w...
November 2019
184 pages
Sepsis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Sepsis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Sepsis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
367 pages
Nicotine Addiction - Pipeline Review, H2 2019
US$ 2,000.00
... . The Nicotine Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Nicotine Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
76 pages
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2019
US$ 2,000.00
... The Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Coronary Artery Disease (CAD) (Ischemic Heart Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
November 2019
232 pages
Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H2 2019
US$ 2,000.00
... . The Gorlin Syndrome (Basal Cell Nevus Syndrome) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Gorlin Syndrome (Basal Cell Nevus Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
148 pages
Facial Injectables Market By Product Type (Dermal Fillers, Botox), By End-user (Hospitals, Dermatology Centers, Physician's Office), By Region (North America, Europe, Asia Pacific, RoW) – Global Forecast up to 2025
US$ 3,250.00
Global Facial Injectables Market by Product Types (Dermal Fillers, Botox), By End-users (Hospitals, Dermatology Centers, Physician’s Office), and By Regions (North America, Europe, Asia Pacific, and R...
November 2019
102 pages
Pediatric Medicines: Global Markets
US$ 5,500.00
REPORT SCOPE: This new report on pediatric medicine will provide a brief overview on the current status of the industry and recent developments. It presents the changing environment in terms of new...
November 2019
169 pages
Global Human Microbiome Market Size study, by Product (Probiotics, Prebiotics, Foods, Medical Foods, Diagnostic Tests and Drugs), By Application (Therapeutics and Diagnostics), By Disease (Infectious Diseases, Inflammatory Diseases, Endocrine & Metabolic Disorders, Cancer and Other Diseases), By Technology (Genomics, Proteomics and Metabolomics) and Regional Forecasts 2019-2026
US$ 3,750.00
Global Human Microbiome Market is valued approximately at USD 291.08 million in 2018 and is anticipated to grow with a healthy growth rate of more than 25% over the forecast period 2019-2026. Human mi...
November 2019
200 pages
Scar - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Scar (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Scar and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
75 pages
West Nile Virus Infections - Pipeline Review, H2 2019
US$ 2,000.00
... . The West Nile Virus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for West Nile Virus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
75 pages
Pseudomonas aeruginosa Infections - Pipeline Review, H2 2019
US$ 2,000.00
... . The Pseudomonas aeruginosa Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pseudomonas aeruginosa Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
282 pages
Atopic Dermatitis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Atopic Dermatitis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Atopic Dermatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
597 pages
Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H2 2019
US$ 2,000.00
... . The Granulomatosis with Polyangiitis (Wegener Polyangiitis) (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Granulomatosis with Polyangiitis (Wegener Polyangiitis) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
November 2019
83 pages
Primary Hyperoxaluria - Pipeline Review, H2 2019
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Primary Hyperoxaluria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
63 pages
C-X-C Chemokine Receptor Type 2 - Pipeline Review, H2 2019
US$ 3,500.00
... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) development landscape Develop ...
November 2019
69 pages
C-C Chemokine Receptor Type 5 - Pipeline Review, H2 2019
US$ 3,500.00
C-C Chemokine Receptor Type 5 - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'C-C Chemokine Receptor Type 5 - Pipeline Review, H2 2019'; C-C Chemokine Receptor Type 5...
November 2019
90 pages
C-X-C Chemokine Receptor Type 4 - Pipeline Review, H2 2019
US$ 3,500.00
C-X-C Chemokine Receptor Type 4 - Pipeline Review, H2 2019 SUMMARY C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopoly...
November 2019
136 pages
Cytotoxic T Lymphocyte Protein 4 - Pipeline Review, H2 2019
US$ 3,500.00
Cytotoxic T Lymphocyte Protein 4 - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'Cytotoxic T Lymphocyte Protein 4 - Pipeline Review, H2 2019'; Cytotoxic T Lymphocyte P...
November 2019
237 pages
E3 Ubiquitin Protein Ligase XIAP - Pipeline Review, H2 2019
US$ 3,500.00
E3 Ubiquitin Protein Ligase XIAP - Pipeline Review, H2 2019 SUMMARY E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protei...
November 2019
83 pages
Ephrin Type B Receptor 4 - Pipeline Review, H2 2019
US$ 3,500.00
Ephrin Type B Receptor 4 - Pipeline Review, H2 2019 SUMMARY Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constit...
November 2019
45 pages
Nasal Polyps - Pipeline Review, H2 2019
US$ 2,000.00
Nasal Polyps - Pipeline Review, H2 2019 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyps - Pipeline Review, H2 2019, provides an overview of t...
November 2019
102 pages
NT 3 Growth Factor Receptor - Pipeline Review, H2 2019
US$ 3,500.00
NT 3 Growth Factor Receptor - Pipeline Review, H2 2019 SUMMARY NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1...
November 2019
74 pages
Prostaglandin D2 Receptor 2 - Pipeline Review, H2 2019
US$ 3,500.00
Prostaglandin D2 Receptor 2 - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'Prostaglandin D2 Receptor 2 - Pipeline Review, H2 2019'; Prostaglandin D2 Receptor 2 (Chemo...
November 2019
61 pages
Retinoic Acid Receptor Alpha - Pipeline Review, H2 2019
US$ 3,500.00
Retinoic Acid Receptor Alpha - Pipeline Review, H2 2019 SUMMARY Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Retinoic acid receptor al...
November 2019
68 pages
Retinoic Acid Receptor Beta - Pipeline Review, H2 2019
US$ 3,500.00
Retinoic Acid Receptor Beta - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'Retinoic Acid Receptor Beta - Pipeline Review, H2 2019'; Retinoic Acid Receptor Beta (RAR B...
November 2019
77 pages
Retinoic Acid Receptor Gamma - Pipeline Review, H2 2019
US$ 3,500.00
Retinoic Acid Receptor Gamma - Pipeline Review, H2 2019 SUMMARY Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) pipeline Target constitutes...
November 2019
82 pages
Survival Motor Neuron Protein - Pipeline Review, H2 2019
US$ 3,500.00
Survival Motor Neuron Protein - Pipeline Review, H2 2019 SUMMARY Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Survival of motor neuron or survival motor neuron (S...
November 2019
85 pages
Bronchitis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Bronchitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
129 pages
Choroidal Neovascularization - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Choroidal Neovascularization (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Choroidal Neovascularization and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
57 pages
Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H2 2019
US$ 2,000.00
... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Interstitial Cystitis (Painful Bladder Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
88 pages
Bone Fracture - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Bone Fracture (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Bone Fracture and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
75 pages
Ependymoma - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Ependymoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ependymoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
237 pages
Systemic Idiopathic Juvenile Arthritis - Pipeline Review, H2 2019
US$ 2,000.00
... . The Systemic Idiopathic Juvenile Arthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Systemic Idiopathic Juvenile Arthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
58 pages
Muscle Atrophy - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Muscle Atrophy (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Muscle Atrophy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
37 pages
Xerostomia - Pipeline Review, H2 2019
US$ 2,000.00
... and Dental Disorders) pipeline guide also reviews of key players involved in therapeutic development for Xerostomia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
37 pages
